Home › Crohn's Disease › Kansas › Topeka
Crohn's Disease clinical trials in Topeka, KS
6 studies for Crohn's Disease are looking for participants at sites in and around Topeka (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Cotton-O'Neil Clinical Research Center, Topeka
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University of Kansas Health System Saint Francis Campus, Topeka
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
RecruitingPhase 2
- Cotton O'Neil Digestive Health Center, Topeka
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RecruitingPhase 2
- Cotton O'Neil Digestive Health Center, Topeka
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RecruitingPhase 3
- Cotton O'Neil Digestive Health Center ( Site 5033), Topeka
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RecruitingPhase 4
- Cotton ONeil Clinical Research Center, Topeka
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Miami, FL19 studies
- Boston, MA19 studies
- St. Louis, MO19 studies
- Cleveland, OH18 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- Orlando, FL17 studies
- Tyler, TX16 studies
- Los Angeles, CA15 studies
- San Antonio, TX15 studies
- San Diego, CA15 studies
Other studies in Topeka
- Overweight7 studies
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer7 studies
- Prostate Cancer7 studies
- Breast Cancer6 studies
- Obesity6 studies
- Lung Cancer6 studies
- Cardiovascular Disease5 studies
- Melanoma4 studies
- Esophageal Cancer4 studies
- Bladder Cancer4 studies
- Type 2 Diabetes4 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.